Peptides in seminal fluid and their role in infertility

A potential role for opiorphin inhibition of neutral endopeptidase activity as a clinically relevant modulator of sperm motility: A review

Jayme S. Bosler, Kelvin Davies, Genevieve S. Neal-Perry

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Infertility is a devastating medical condition that adversely affects emotional health and well-being of couples who desire pregnancy and parenthood. The overall demographic data suggest that the indication for more than one-third of assisted reproductive technology cycles performed in the United States includes male factor infertility. There is increasing recognition of the role that peptides present in seminal plasma have in determining sperm motility. Several recent studies suggest that peptidases, such as neutral endopeptidase (NEP) and aminopeptidase N (APN), impose significant adverse effects on sperm motility. Interestingly, several recent studies demonstrate that there is an endogenous NEP/APN inhibitor peptide called opiorphin in human seminal plasma. Our pilot studies suggest opiorphin promotes sperm motility and may positively influence sperm motility parameters in some cases of males infertility characterized by asthenozoospermia.

Original languageEnglish (US)
Pages (from-to)1334-1340
Number of pages7
JournalReproductive Sciences
Volume21
Issue number11
DOIs
StatePublished - Nov 12 2014

Fingerprint

glutaminyl-arginyl-phenylalanyl-seryl-arginine
Neprilysin
Sperm Motility
Infertility
CD13 Antigens
Peptides
Male Infertility
Semen
Asthenozoospermia
Assisted Reproductive Techniques
Peptide Hydrolases
Demography
Pregnancy
Health

Keywords

  • Male infertility
  • Seminal peptides
  • Sperm motility

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

@article{60419ea92812411689b2a049b365baf0,
title = "Peptides in seminal fluid and their role in infertility: A potential role for opiorphin inhibition of neutral endopeptidase activity as a clinically relevant modulator of sperm motility: A review",
abstract = "Infertility is a devastating medical condition that adversely affects emotional health and well-being of couples who desire pregnancy and parenthood. The overall demographic data suggest that the indication for more than one-third of assisted reproductive technology cycles performed in the United States includes male factor infertility. There is increasing recognition of the role that peptides present in seminal plasma have in determining sperm motility. Several recent studies suggest that peptidases, such as neutral endopeptidase (NEP) and aminopeptidase N (APN), impose significant adverse effects on sperm motility. Interestingly, several recent studies demonstrate that there is an endogenous NEP/APN inhibitor peptide called opiorphin in human seminal plasma. Our pilot studies suggest opiorphin promotes sperm motility and may positively influence sperm motility parameters in some cases of males infertility characterized by asthenozoospermia.",
keywords = "Male infertility, Seminal peptides, Sperm motility",
author = "Bosler, {Jayme S.} and Kelvin Davies and Neal-Perry, {Genevieve S.}",
year = "2014",
month = "11",
day = "12",
doi = "10.1177/1933719114536473",
language = "English (US)",
volume = "21",
pages = "1334--1340",
journal = "Reproductive Sciences",
issn = "1933-7191",
publisher = "SAGE Publications Inc.",
number = "11",

}

TY - JOUR

T1 - Peptides in seminal fluid and their role in infertility

T2 - A potential role for opiorphin inhibition of neutral endopeptidase activity as a clinically relevant modulator of sperm motility: A review

AU - Bosler, Jayme S.

AU - Davies, Kelvin

AU - Neal-Perry, Genevieve S.

PY - 2014/11/12

Y1 - 2014/11/12

N2 - Infertility is a devastating medical condition that adversely affects emotional health and well-being of couples who desire pregnancy and parenthood. The overall demographic data suggest that the indication for more than one-third of assisted reproductive technology cycles performed in the United States includes male factor infertility. There is increasing recognition of the role that peptides present in seminal plasma have in determining sperm motility. Several recent studies suggest that peptidases, such as neutral endopeptidase (NEP) and aminopeptidase N (APN), impose significant adverse effects on sperm motility. Interestingly, several recent studies demonstrate that there is an endogenous NEP/APN inhibitor peptide called opiorphin in human seminal plasma. Our pilot studies suggest opiorphin promotes sperm motility and may positively influence sperm motility parameters in some cases of males infertility characterized by asthenozoospermia.

AB - Infertility is a devastating medical condition that adversely affects emotional health and well-being of couples who desire pregnancy and parenthood. The overall demographic data suggest that the indication for more than one-third of assisted reproductive technology cycles performed in the United States includes male factor infertility. There is increasing recognition of the role that peptides present in seminal plasma have in determining sperm motility. Several recent studies suggest that peptidases, such as neutral endopeptidase (NEP) and aminopeptidase N (APN), impose significant adverse effects on sperm motility. Interestingly, several recent studies demonstrate that there is an endogenous NEP/APN inhibitor peptide called opiorphin in human seminal plasma. Our pilot studies suggest opiorphin promotes sperm motility and may positively influence sperm motility parameters in some cases of males infertility characterized by asthenozoospermia.

KW - Male infertility

KW - Seminal peptides

KW - Sperm motility

UR - http://www.scopus.com/inward/record.url?scp=84909630913&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84909630913&partnerID=8YFLogxK

U2 - 10.1177/1933719114536473

DO - 10.1177/1933719114536473

M3 - Article

VL - 21

SP - 1334

EP - 1340

JO - Reproductive Sciences

JF - Reproductive Sciences

SN - 1933-7191

IS - 11

ER -